Another CRISPR Trial Begins – GenomeWeb


Asian Scientist Magazine

Another CRISPR Trial Begins
GenomeWeb
Researchers in China have embarked on a new trial using the gene-editing tool CRISPR/Cas9 to modify human genes to treat cancer patients, the Wall Street Journal reports. For this trial, researchers at Nanjing University have injected the first set of
China Is Racing Ahead of the US in the Quest to Cure Cancer With CRISPRGizmodo


CRISPR Used To Modify Multiple Genes In RiceAsian Scientist Magazine
-$0.51 Earnings Per Share Expected for Crispr Therapeutics AG …The Cerbat Gem
Wall Street Journal (subscription) –Transcript Daily
all 18 news articles »

2017-04-28 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.